Euclidean Technologies Management LLC Takes Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

Euclidean Technologies Management LLC acquired a new stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 263 shares of the biopharmaceutical company’s stock, valued at approximately $216,000. Other institutional investors and […]

Related Keywords

Canada ,Michaels Brown ,Marion Mccourt ,Insider Activity At Regeneron Pharmaceuticals ,Wells Fargo Company ,Nasdaq ,Euclidean Technologies Management ,Exchange Commission ,Quarter For Regeneron Pharmaceuticals ,Royal Bank ,Regeneron Pharmaceuticals Trading ,Regeneron Pharmaceuticals Inc ,Lindbrook Capital ,Jennison Associates ,Regeneron Pharmaceuticals Profile ,Regeneron Pharmaceuticals ,News Ratings For Regeneron Pharmaceuticals Daily ,Caprock Group ,Free Report ,Wealth Partners ,Tower Bridge Advisors ,Bridge Advisors ,Get Free Report ,Director Michael ,Visit Holdingschannel ,Regeneron Pharmaceuticals Daily ,